Skip to main content

Peer Review reports

From: Blood biomarkers as surrogate endpoints of treatment responses to aerobic exercise and cognitive training (ACT) in amnestic mild cognitive impairment: the blood biomarkers study protocol of a randomized controlled trial (the ACT Trial)

Original Submission
17 Jul 2019 Submitted Original manuscript
6 Sep 2019 Reviewed Reviewer Report - Kirsty Loudon
7 Oct 2019 Author responded Author comments - Danni Li
Resubmission - Version 2
7 Oct 2019 Submitted Manuscript version 2
11 Oct 2019 Editorially accepted
6 Jan 2020 Article published 10.1186/s13063-019-3798-1

You can find further information about peer review here.

Back to article page